Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

243 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Do GC/MS methods available for furan and alkylfurans in food provide comparable results? - An interlaboratory study and safety assessment of 2-pentylfuran in food.
Frank N, Delatour T, Dubois M, Novotny O, Dufossé T, Mollergues J, Scholz G, Moulin J. Frank N, et al. Among authors: moulin j. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2024 Jan;41(1):22-32. doi: 10.1080/19440049.2023.2297433. Epub 2024 Jan 17. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2024. PMID: 38170576
Adjuvant treatment with S-1 in patients after R0-resection of adenocarcinoma of the stomach and esophagogastric junction - A multicenter phase I/II feasibility study (GMBH-STO-0114).
Heinrich K, Heinemann V, Stintzing S, Müller L, Ettrich TJ, Buechner-Steudel P, Geißler M, Trojan J, Moosmann N, Folprecht G, Schmidt J, Kanzler S, Kullmann F, Moulin JC, Werner J, Angele MK, Probst V, Held S, Schulz C, Boukovala M. Heinrich K, et al. Among authors: moulin jc. Oncol Res Treat. 2024 Apr 2. doi: 10.1159/000538143. Online ahead of print. Oncol Res Treat. 2024. PMID: 38565089
Ramucirumab plus irinotecan / leucovorin / 5-FU versus ramucirumab plus paclitaxel in patients with advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction, who failed one prior line of palliative chemotherapy: the phase II/III RAMIRIS study (AIO-STO-0415).
Lorenzen S, Schwarz A, Pauligk C, Goekkurt E, Stocker G, Knorrenschild JR, Illerhaus G, Dechow T, Moehler M, Moulin JC, Pink D, Stahl M, Schaaf M, Goetze TO, Al-Batran SE. Lorenzen S, et al. Among authors: moulin jc. BMC Cancer. 2023 Jun 19;23(1):561. doi: 10.1186/s12885-023-11004-z. BMC Cancer. 2023. PMID: 37337155 Free PMC article. Clinical Trial.
Advice on describing Bayesian analysis of neutron and X-ray reflectometry.
McCluskey AR, Caruana AJ, Kinane CJ, Armstrong AJ, Arnold T, Cooper JFK, Cortie DL, Hughes AV, Moulin JF, Nelson ARJ, Potrzebowski W, Starostin V. McCluskey AR, et al. Among authors: moulin jf. J Appl Crystallogr. 2023 Feb 1;56(Pt 1):12-17. doi: 10.1107/S1600576722011426. eCollection 2023 Feb 1. J Appl Crystallogr. 2023. PMID: 36777146 Free PMC article. Review.
Neglected geriatric assessment and overtreatment of older patients with pancreatic cancer - Results from a prospective phase IV clinical trial.
Betge J, Schulte N, Belle S, Zhan T, Krammer-Steiner B, Moulin JC, Kleiß M, Lammert F, Wedding U, Räth S, Maenz M, Hegele L, Larcher-Senn J, Jesenofsky R, Ebert MP, Härtel N. Betge J, et al. Among authors: moulin jc. J Geriatr Oncol. 2022 Jun;13(5):662-666. doi: 10.1016/j.jgo.2021.12.018. Epub 2022 Jan 3. J Geriatr Oncol. 2022. PMID: 34991998 Clinical Trial.
243 results